ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,127Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 676

$1.43M Total Retail Price of All Prescriptions

Rank: 19 out of 676

754 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 754 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 754 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 23,000 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
LISINOPRIL 1,160 892 1 5
AMLODIPINE BESYLATE 1,025 888 2 3
FUROSEMIDE 1,019 883 3 4
OMEPRAZOLE 971 772 4 2
POTASSIUM CHLORIDE 792 643 5 9
WARFARIN SODIUM 665 590 6 18
CARVEDILOL 664 543 7 15
SIMVASTATIN 629 519 8 6
ATORVASTATIN CALCIUM 619 436 9 20
CITALOPRAM HBR 524 386 10 17
LEVOTHYROXINE SODIUM 519 447 11 7
DONEPEZIL HCL 496 469 12 24
METOPROLOL TARTRATE 480 393 13 22
METOPROLOL SUCCINATE 477 454 14 14
POLYETHYLENE GLYCOL 3350 468 398 15 56
GABAPENTIN 443 341 16 10
HYDROCODONE-ACETAMINOPHEN 396 300 S3 17 1
LOSARTAN POTASSIUM 341 319 18 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 331 250 19 16
ZOLPIDEM TARTRATE 327 214 20 21
METFORMIN HCL ER 323 250 21 63
METFORMIN HCL 311 174 22 8
LOSARTAN-HYDROCHLOROTHIAZIDE 295 256 23 51
NAMENDA 288 258 24 35
HYDROCHLOROTHIAZIDE 286 234 25 12
RANITIDINE HCL 280 187 26 27
PRAVASTATIN SODIUM 275 204 27 11
TAMSULOSIN HCL 266 177 28 38
GLIMEPIRIDE 262 217 29 30
NEXIUM 250 236 30 23
LOVASTATIN 244 173 31 33
KLOR-CON 10 229 173 32 95
SPIRONOLACTONE 227 187 33 62
ALLOPURINOL 216 128 34 31
CRESTOR 212 173 35 29
QUETIAPINE FUMARATE 202 170 36 72
TORSEMIDE 196 186 37 159
JANUVIA 188 124 38 78
RISPERIDONE 181 124 39 69
CLOPIDOGREL 179 127 40 28
NAPROXEN 178 138 41 71
LEVEMIR 170 134 42 157
JANTOVEN 165 157 43 156
SERTRALINE HCL 158 138 44 26
LEVEMIR FLEXPEN 152 85 45 192
ISOSORBIDE MONONITRATE ER 148 96 46 54
ESCITALOPRAM OXALATE 143 123 47 73
MIRTAZAPINE 140 135 48 59
PLAVIX 135 104 49 40
TRAMADOL HCL 130 94 50 19
SULFAMETHOXAZOLE-TRIMETHOPRIM 129 100 51 74
ATENOLOL 127 106 52 25
DIVALPROEX SODIUM 123 90 53 99
PANTOPRAZOLE SODIUM 121 94 54 42
PROPRANOLOL HCL 120 82 55 120
DIGOXIN 119 113 56 52
PREDNISONE 116 91 57 53
FLUTICASONE PROPIONATE 115 76 58 49
PHENYTOIN SODIUM EXTENDED 113 62 59 88
HYDRALAZINE HCL 112 66 60 77
FLUOXETINE HCL 106 45 61 70
AZITHROMYCIN 104 82 62 39
FINASTERIDE 102 90 63 197
LANTUS 101 81 64 55
NOVOLOG 99 67 65 134
MELOXICAM 98 67 66 13
DILTIAZEM ER 95 69 67 118
SYNTHROID 94 89 68 48
OLANZAPINE 93 53 69 125
AMLODIPINE BESYLATE-BENAZEPRIL 91 80 70 44
BENAZEPRIL HCL 91 70 70 58
EXELON 91 91 70 130
MUPIROCIN 90 70 73 146
SEROQUEL 90 79 73 135
LEVETIRACETAM 87 51 75 138
LIPITOR 87 60 75 94
DEXILANT 87 62 75 155
OXYBUTYNIN CHLORIDE ER 85 71 78 175
ADVAIR DISKUS 85 67 78 87
COUMADIN 85 85 78 193
VYTORIN 84 63 81 176
DIOVAN 84 72 81 37
BENZTROPINE MESYLATE 83 40 R 83 129
DILTIAZEM 24HR ER 80 75 84 215
DETROL LA 79 58 85 166
NOVOLIN R 78 58 86 153
EVISTA 77 77 87 119
CARBIDOPA-LEVODOPA 75 62 88 114
CYMBALTA 74 71 89 47
LANSOPRAZOLE 74 73 89 171
HUMALOG 73 58 91 230
LEVOTHROID 72 59 92 268
VALPROIC ACID 72 31 92 229
CIPROFLOXACIN HCL 71 61 94 45
AMITRIPTYLINE HCL 71 71 R 94 46
SPIRIVA 68 54 96 97
COLCRYS 67 46 97 122
AVODART 67 67 97 199
NOVOLOG FLEXPEN 67 31 97 226
PAROXETINE HCL 66 54 100 65
BETAMETHASONE DIPROPIONATE 66 58 100 344
ENALAPRIL MALEATE 64 58 102 65
LOVAZA 62 47 103 183
PROAIR HFA 62 47 103 79
MEGESTROL ACETATE 61 61 R 105 111
DIOVAN HCT 61 55 105 41
SINGULAIR 61 46 105 80
BACLOFEN 59 34 108 144
LEXAPRO 59 50 108 210
ZETIA 58 58 110 89
CARBAMAZEPINE 58 41 110 217
METOCLOPRAMIDE HCL 57 57 112 107
PHENYTOIN 57 42 112 297
BYSTOLIC 56 40 114 96
GEMFIBROZIL 56 26 114 137
INSULIN SYRINGE 55 49 116 161
ROPINIROLE HCL 54 54 117 85
AMOXICILLIN 53 48 118 105
DILTIAZEM 24HR CD 52 52 119 152
IBUPROFEN 51 28 120 102
ALPHAGAN P 51 50 120 344
TRAVATAN Z 50 34 122 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.